Does PEMBROLIZUMAB Cause Thrombocytopenia? 1,452 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,452 reports of Thrombocytopenia have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 1.7% of all adverse event reports for PEMBROLIZUMAB.
1,452
Reports of Thrombocytopenia with PEMBROLIZUMAB
1.7%
of all PEMBROLIZUMAB reports
208
Deaths
608
Hospitalizations
How Dangerous Is Thrombocytopenia From PEMBROLIZUMAB?
Of the 1,452 reports, 208 (14.3%) resulted in death, 608 (41.9%) required hospitalization, and 147 (10.1%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which PEMBROLIZUMAB Alternatives Have Lower Thrombocytopenia Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G